Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Non-Current Deferred Tax Liability (2020)

Cue Biopharma (CUE) has disclosed Non-Current Deferred Tax Liability for 1 consecutive years, with -$2000.0 as the latest value for Q4 2020.

  • Quarterly Non-Current Deferred Tax Liability changed N/A to -$2000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$2000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at -$2000.0 for FY2020, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability hit -$2000.0 in Q4 2020 for Cue Biopharma.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of -$2000.0 in Q4 2020 to a low of -$2000.0 in Q4 2020.